Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Changing endocrine therapy from SERMs to AIs in perimenopausal breast cancer
NCT02097459Phase 3Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Mar 2014
- Primary completion
- Mar 2024
- Countries
- 1
01
Overview
A Phase 3 trial of anastrozole in breast cancer, sponsored by Peking Union Medical College Hospital. Status: unknown.
02
Drugs
anastrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02097459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02097459.